Hancock Whitney’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,088
Closed -$315K 638
2022
Q3
$315K Sell
13,088
-376
-3% -$11.6K 0.01% 515
2022
Q2
$423K Sell
13,464
-5
-0% -$181 0.02% 455
2022
Q1
$594K Buy
13,469
+143
+1% +$6.14K 0.02% 423
2021
Q4
$580K Sell
13,326
-69
-0.5% -$2.71K 0.02% 451
2021
Q3
$419K Buy
13,395
+59
+0.4% +$2.32K 0.01% 514
2021
Q2
$564K Sell
13,336
-53
-0.4% -$2.06K 0.02% 527
2021
Q1
$504K Sell
13,389
-9,860
-42% -$308K 0.02% 545
2020
Q4
$628K Sell
23,249
-1,641
-7% -$42.2K 0.02% 476
2020
Q3
$625K Sell
24,890
-15,919
-39% -$232K 0.02% 465
2020
Q2
$311K Buy
+40,809
New +$299K 0.01% 612
2018
Q1
Sell
-24,482
Closed -$463K 591
2017
Q4
$463K Buy
+24,482
New +$543K 0.02% 451
2014
Q2
Sell
-10,600
Closed -$371K 523
2014
Q1
$371K Hold
10,600
0.01% 453
2013
Q4
$388K Buy
+10,600
New +$389K 0.02% 429

Other funds holding ACH

Hancock Whitney's ACH Position: Q4 2022 in Review

Hancock Whitney sold out of Accendra Health (ACH) in Q4 2022, closing a stake of 13,088 shares — an estimated $315K sold.

Hancock Whitney first reported a position in ACH in Q4 2013 and held it in 13 quarters. The position peaked at $628K in Q4 2020. 219 funds tracked by Wall St. Rank hold ACH as of Q4 2022.

  • Hancock Whitney reported no remaining Accendra Health position as of Q4 2022 after selling out during the quarter.
  • Hancock Whitney sold 13,088 Accendra Health shares in Q4 2022, an estimated $315K.
  • Hancock Whitney first reported a position in Accendra Health in Q4 2013 and held it in 13 quarters.
  • Hancock Whitney's Accendra Health position peaked at $628K in Q4 2020.
  • 219 funds tracked by Wall St. Rank held Accendra Health as of Q4 2022.

Based on Hancock Whitney's 13F filing for Q4 2022, filed 3 Feb 2023.